ILAR category | Total AITD (n = 96) | Hashimoto’s disease (n = 58) | Graves’ disease (= 4) | Unspecified AITD (n = 34) |
---|---|---|---|---|
Enthesitis-related arthritis | 8 (8.3%) | 6 (10.3%) | 0 (0.0%) | 2 (5.9%) |
Oligoarthritis | 32 (33.3%) | 17 (29.3%) | 3 (75.0%) | 12 (35.3%) |
Polyarthritis (RF-) | 30 (31.3%) | 21 (36.2%) | 0 (0.0%) | 9 (26.5%) |
Polyarthritis (RF+) | 9 (9.4%) | 4 (6.9%) | 0 (0.0%) | 5 (14.7%) |
Psoriatic arthritis | 6 (6.2%) | 3 (5.2%) | 1 (25.0%) | 2 (5.9%) |
Systemic arthritis | 2 (2.1%) | 1 (1.7%) | 0 (0.0%) | 1 (2.9%) |
Undifferentiated arthritis | 9 (9.4%) | 6 (10.3%) | 0 (0.0%) | 3 (8.8%) |